Modification of human serum albumin with N-(2,5-dinitro-4-fluorophenyl)-4-amino-2,2,6,6-tetramethyl-piperidinooxy radical.
Human serum albumin has been treated with the spin-labeling reagent indicated in the title. Ultraviolet spectral studies of the protein so modified suggest that reaction takes place at lysine and tyrosine sidechains; kinetic experiments indicate that there are two especially reactive amino groups of the protein which are preferentially modified. Evidence is presented that these groups include the one acetylated by aspirin (Lys-199) or those arylated by 2.6-dinitro-4-trifluoromethylbenzenesulfonate. Esr experiments show that bound spin labels have about the same correlation time expected for overall tumbling of the protein; ESR observations indicate that molecular freedom near the spin labels is not increased when the protein is transferred to 8 M urea.
D001665:Binding Sites; D003497:Cyclic N-Oxides / Q000138:chemical synthesis; D004578:Electron Spin Resonance Spectroscopy; D006801:Humans; D007700:Kinetics; D010880:Piperidines / Q000138:chemical synthesis; D012709:Serum Albumin; D013113:Spin Labels / Q000138:chemical synthesis
D003497:Cyclic N-Oxides; D010880:Piperidines; D012709:Serum Albumin; D013113:Spin Labels; C023669:N-(2,5-dinitro-4-fluorophenyl)-4-amino-2,2,6,6-tetramethylpiperidinooxy